Pro-calcitonin Marker as Indicator of Ischemia in Patients With Complicated Coronary Intervention.
This trial is active, not recruiting.
|Sponsor||Saint Michael's Medical Center|
|Start date||May 2012|
|End date||April 2014|
|Trial size||100 participants|
|Trial identifier||NCT01609569, #09/12|
The aim of this study is to determine on preliminary basis weather an elevated pro-calcitonin level can be used to assess ischemia as a result of coronary artery complications during percutaneous coronary intervention (PCI).
patients with coronary complication and patients without coronary complications. pro-calcitonin will be measured in both groups to see if any correlation.
Pro-calcitonin blood level
time frame: "0,24 hours post cardiac intervention"
Male or female participants at least 18 years old.
Inclusion Criteria: - patients older than 18 years old. Exclusion Criteria: - no consent. - suspicion of sepsis. - Patients with elevated troponin or procalcitonin before enrollment. - patients who had non-elective angioplasty (e.g. rescue angioplasty, primary angioplasty, salvage angioplasty, or emergency angioplasty)
|Official title||Utility of Pro-calcitonin as an Indicator of Ischemia in Patients Undergoing Percutaneous Coronary Intervention With Subsequent Coronary Complications.|
|Principal investigator||Habib Habib, MD|
|Description||Pro-calcitonin is a type of protein found in the blood. This protein has recently be found to be elevated in patients with diseases of the arteries of the heart such as heart attack. Percutaneous coronary intervention (PCI) is widely used in the treatment of many patients with blockage in the arteries of the heart. the investigators normally used a marker called troponin after cardiac catheterization. However, this marker may not be specific. Pro-calcitonin has been found to be a useful marker for the detection of myocardial injury. the value of Pro-calcitonin as a marker for the identification of myocardial damage undergoing PCI has not yet been studied.|
Call for more information